Hybrid polymeric hydrogels for ocular drug delivery: Nanoparticulate systems from copolymers of acrylic acid-functionalized chitosan and N-isopropylacrylamide or 2-hydroxyethyl methacrylate

Nanotechnology

Volumn 20, Issue 22, 2009, Pages

  Barbu, Eugen ^a   Verestiuc, Liliana ^b   Iancu, Mihaela ^c   Jatariu, Anca ^c   Lungu, Adriana ^d   Tsibouklis, John ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c GHEORGHE ASACHI TECHNICAL UNIVERSITY OF IASI   (Romania)

^d UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

2-HYDROXYETHYL METHACRYLATE; ACRYLIC ACIDS; AQUEOUS SOLUBILITY; CANDIDATE DRUGS; CONTROLLED RELEASE; COPOLYMERS OF ACRYLIC ACID; FUNCTIONALIZED; HYBRID NANOPARTICLE; IN-VITRO; MUCOSAL SURFACE; N-ISOPROPYLACRYLAMIDE; NANO PARTICULATES; NANOPARTICULATE SYSTEM; NETWORK STRUCTURES; OCULAR DRUG DELIVERY; OPHTHALMIC DRUG DELIVERY; POLYMERIC HYDROGELS; SWELLING CHARACTERISTICS; SWELLING PROPERTIES; TEMPERATURE SENSITIVITY;

ACRYLIC MONOMERS; AMIDES; BIODEGRADATION; BIOMATERIALS; CARBOXYLIC ACIDS; CHITIN; CHITOSAN; CONTROLLED DRUG DELIVERY; FUNCTIONAL POLYMERS; HYBRID MATERIALS; HYBRID SYSTEMS; NANOPARTICLES; ORGANIC ACIDS; POLYMERS;

HYDROGELS;

2 HYDROXYETHYL METHACRYLATE; ACRYLIC ACID COPOLYMER; ATROPINE; CHITOSAN; CHLORAMPHENICOL; LYSOZYME; NANOCARRIER; NANOPARTICLE; NORFLOXACIN; PILOCARPINE; POLY(N ISOPROPYLACRYLAMIDE); ACRYLAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; METHACRYLIC ACID DERIVATIVE; N ISOPROPYLACRYLAMIDE; N-ISOPROPYLACRYLAMIDE;

AQUEOUS SOLUTION; ARTICLE; BIODEGRADABILITY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; HYDROGEL; POLYMERIZATION; PRIORITY JOURNAL; SWELLING; TEMPERATURE SENSITIVITY; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG STABILITY; EYE; HUMAN; KINETICS; METHODOLOGY; PARTICLE SIZE; TEMPERATURE; THEORETICAL MODEL; ULTRASTRUCTURE;

ACRYLAMIDES; ANTI-BACTERIAL AGENTS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EYE; HUMANS; HYDROGELS; KINETICS; METHACRYLATES; MODELS, THEORETICAL; MURAMIDASE; NANOPARTICLES; PARTICLE SIZE; TEMPERATURE;

EID: 67649154124     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/20/22/225108     Document Type: Article

References (35)

1. Sahoo S K, Dilnawaz F and Krishnakumar S 2008 Nanotechnology in ocular drug delivery Drug Discov. Today 13 144-51
2. Cai X, Conley S and Naash M 2008 Nanoparticle applications in ocular gene therapy: retinal degeneration and gene therapy-retinal degeneration Vis. Res. 48 319-24
3. Kothuri M K 2003 Ophthalmic Drug Delivery Systems (New York: Dekker)
4. Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F and Gurny R 2003 Cyclosporine a delivery to the eye: a pharmaceutical challenge Eur. J. Pharm. Biopharm. 56 307-18 (Pubitemid 37346503)
5. Diebold Y, Jarrin M, Saez V, Carvalho E L S, Orea M, Calonge M, Seijo B and Alonso M J 2007 Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP) Biomaterials 28 1553-64 (Pubitemid 46027250)
6. Yuan X B, Li H and Yuan Y B 2006 Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface Carbohydr. Polym. 65 337-45 (Pubitemid 44160627)
7. De Campos A M, Sanchez A and Alonso M J 2001 Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A Int. J. Pharm. 224 159-68 (Pubitemid 32706495)
8. Alonso M J and Sanchez A 2003 The potential of chitosan in ocular drug delivery J. Pharm. Pharmacol. 55 1451-63 (Pubitemid 37441350)
9. Paul W and Sharma C P 2000 Chitosan, a drug carrier for the 21st century: a review Stp Pharma Sci. 10 5-22 (Pubitemid 30126781)
10. De Salamanca A E, Diebold Y, Calonge M, Garcia-Vazquez C, Callejo S, Vila A and Alonso M J 2006 Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance Invest. Ophthalmol. Vis. Sci. 47 1416-25 (Pubitemid 46780748)
11. Vandervoort J and Ludwig A 2007 Ocular drug delivery: nanomedicine applications Nanomedicine 2 11-21 (Pubitemid 46845773)
12. Kaur I P, Garg A, Singla A K and Aggarwal D 2004 Vesicular systems in ocular drug delivery: an overview Int. J. Pharm. 269 1-14 (Pubitemid 38035207)
13. De Campos A M, Sanchez A, Gref R, Calvo P and Alonso M J 2003 The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa Eur. J. Pharm. Sci. 20 73-81 (Pubitemid 37103234)
14. Verestiuc L, Nastasescu O, Barbu E, Sarvaiya I, Green K L and Tsibouklis J 2006 Functionalized chitosan/nipam (hema) hybrid polymer networks as inserts for ocular drug delivery: synthesis, in vitro assessment, and in vivo evaluation J. Biomed. Mater. Res. A 77 726-35 (Pubitemid 47233554)
15. Gulsen D and Chauhan A 2004 Ophthalmic drug delivery through contact lenses Invest. Ophthalmol. Vis. Sci. 45 2342-7 (Pubitemid 38902607)
16. Maldonado-Codina C and Efron N 2004 Impact of manufacturing technology and material composition on the mechanical properties of hydrogel contact lenses Ophthalmic. Physiol. 24 551-61 (Pubitemid 41710992)
17. Montheard J-P, Chatzopoulos M and Chappard D 1992 2-hydroxyethyl methacrylate (HEMA). Chemical properties and applications in biomedical fields J. Macromol. Sci. Rev. Macromol. Chem. Phys. C32 1-34
18. Kim J and Chauhan A 2008 Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels Int. J. Pharm. 353 205-22
19. Gulsen D and Chauhan A 2005 Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle Int. J. Pharm. 292 95-117 (Pubitemid 40255792)
20. Karlgard C C S, Wong N S, Jones L W and Moresoli C 2003 In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials Int. J. Pharm. 257 141-51 (Pubitemid 36507040)
21. Cao Y, Zhang C, Shen W, Cheng Z, Yu L L and Ping Q 2007 Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery J. Control. Release 120 186-94 (Pubitemid 47058641)
22. Liu L and Sheardown H 2005 Glucose permeable poly(dimethyl siloxane) poly(N-isopropyl acrylamide) interpenetrating networks as ophthalmic biomaterials Biomaterials 26 233-44 (Pubitemid 38950708)
23. Ruel-Gariepy E and Leroux J C 2004 In situ-forming hydrogels-review of temperature-sensitive systems Eur. J. Pharm. Biopharm. 58 409-26
24. Hsiue G H, Chang R W, Wang C H and Lee S H 2003 Development of in situ thermosensitive drug vehicles for glaucoma therapy Biomaterials 24 2423-30
25. Wade A 1980 Pharmaceutical Handbook 19th edn (London: The Pharmaceutical Press) p239
26. Sze A, Erickson D, Ren L Q and Li D Q 2003 Zeta-potential measurement using the smoluchowski equation and the slope of the current-time relationship in electroosmotic flow J. Colloid Interface Sci. 261 402-10 (Pubitemid 36535454)
27. Muzzarelli R A A, Mattioli-Belmonte M, Miliani M, Muzzarelli C, Gabbanelli F and Biagini G 2002 In vivo and in vitro biodegradation of oxychitin-chitosan and oxypullulan-chitosan complexes Carbohydr. Polym. 48 15-21 (Pubitemid 34000350)
28. Qian F, Cui F Y and Yin C H 2006 Preparation, characterization and enzyme inhibition of methylmethacrylate copolymer nanoparticles with different hydrophilic polymeric chains Eur. Polym. J. 42 1653-61 (Pubitemid 43849696)
29. Ding H, Wu F, Huang Y, Zhang Z R and Nie Y 2006 Synthesis and characterization of temperature-responsive copolymer of pelga modified poly(n-isopropylacrylamide) Polymer 47 1575-83 (Pubitemid 43238198)
30. Martien R, Loretz B, Sandbichler A M and Schnurch A B 2008 Thiolated chitosan nanoparticles: transfection study in the caco-2 differentiated cell culture Nanotechnology 19 045101
31. Wu C and Zhou S Q 1995 Laser-light scattering study of the phase-transition of poly(n-isopropylacrylamide) in water. 1. Single-chain Macromolecules 28 8381-7
32. Peppas N A, Bures P, Leobandung W and Ichikawa H 2000 Hydrogels in pharmaceutical formulations Eur. J. Pharm. Biopharm. 50 27-46 (Pubitemid 30326687)
33. Hariharan D and Peppas N A 1993 Swelling of ionic and neutral polymer networks in ionic-solutions J. Membr. Sci. 78 1-12 (Pubitemid 23130514)
34. Aine E and Morsky P 1984 Lysozyme concentration in tears-assessment of reference values in normal subjects Acta Ophthalmol. 62 932-8 (Pubitemid 15183984)
35. Jalbert C, Koberstein J T, Hariharan A and Kumar S K 1997 End group effects on surface properties of polymers: semiempirical calculations and comparison to experimental surface tensions for alpha, omega-functional poly(dimethylsiloxanes) Macromol. 30 4481-90 (Pubitemid 127567567)